AAAAAA

   
Results: 1-8 |
Results: 8
Lamivudine treatment for HBV infection following thoracic organ transplantation
Authors: Grossi, P Dalla Gasperina, D Furione, M Vigano, M Minoli, L
Citation: P. Grossi et al., Lamivudine treatment for HBV infection following thoracic organ transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1576-1578
Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles
Authors: Cerino, A Meola, A Segagni, L Furione, M Marciano, S Triyatni, M Liang, TJ Nicosia, A Mondelli, MU
Citation: A. Cerino et al., Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles, J IMMUNOL, 167(7), 2001, pp. 3878-3886
Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections
Authors: Hu, YW Balaskas, E Furione, M Yen, PH Kessler, G Scalia, V Chui, L Sher, G
Citation: Yw. Hu et al., Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections, J CLIN MICR, 38(8), 2000, pp. 2807-2813
High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders
Authors: Baldanti, F Grossi, P Furione, M Simoncini, L Sarasini, A Comoli, P Maccario, R Fiocchi, R Gerna, G
Citation: F. Baldanti et al., High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders, J CLIN MICR, 38(2), 2000, pp. 613-619
HCV genotyping by three methods: analysis of discordant results based on sequencing
Authors: Furione, M Simoncini, L Gatti, M Baldanti, F Revello, MG Gerna, G
Citation: M. Furione et al., HCV genotyping by three methods: analysis of discordant results based on sequencing, J CLIN VIRO, 13(3), 1999, pp. 121-130
Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determinedby nucleic acid sequence-based amplification
Authors: Gerna, G Baldanti, F Middeldorp, JM Furione, M Zavattoni, M Lilleri, D Revello, MG
Citation: G. Gerna et al., Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determinedby nucleic acid sequence-based amplification, J CLIN MICR, 37(4), 1999, pp. 902-911
Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses
Authors: Revello, MG Zavattoni, M Furione, M Baldanti, F Gerna, G
Citation: Mg. Revello et al., Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses, J CLIN MICR, 37(10), 1999, pp. 3350-3352
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders
Authors: Lazzarino, M Orlandi, E Baldanti, F Furione, M Pagnucco, G Astori, C Arcaini, L Viglio, A Paulli, M Gerna, G Bernasconi, C
Citation: M. Lazzarino et al., The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders, BR J HAEM, 107(4), 1999, pp. 877-882
Risultati: 1-8 |